Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5374 studies found for:    vaccination
Show Display Options
Rank Status Study
1 Completed Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine
Condition: Influenza
Interventions: Biological: Vaccination with Fluval P and Fluval AB influenza vaccines;   Biological: Vaccination with Fluval P monovalent influenza vaccine
2 Recruiting Safety Study Of Anakinra Combined With Chemotherapy And Dendritic Cell Vaccine to Treat Breast Cancer
Condition: Breast Cancer
Interventions: Biological: DC vaccination+Preop chemotherapy;   Biological: DC vaccination+Preop chemo+anakinra
3 Completed Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination
Condition: Cystic Fibrosis With Gastrointestinal Manifestation
Intervention: Biological: influenza vaccination
4 Completed Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children
Condition: Influenza
Intervention: Biological: Vaccination with FLUVAL P
5 Active, not recruiting Prospective Trial of Vaccine Responses in Childhood Cancer Survivors
Conditions: Childhood Cancer;   Multiple Diseases
Interventions: Biological: Immunization Schedule patients <7 years.;   Biological: Immunization Schedule patients > or = to 7 years and <11 years of age;   Biological: Immunization Schedule patients > or = to 11 years of age
6 Completed Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons
Condition: Influenza
Intervention: Biological: Vaccination with Fluval AB influenza vaccine
7 Completed Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents
Conditions: Novel 2009 Influenza H1N1;   Influenza, Human
Interventions: Biological: Vaccination with Fluval P monovalent influenza vaccine;   Biological: Vaccination with Fluval AB;   Biological: Vaccination with Fluval AB Novo
8 Recruiting Multiple Antigen-Engineered DC Vaccine for Melanoma
Condition: Melanoma
Interventions: Biological: DC Vaccine + IFN;   Biological: AdVTMM2/DC Vaccination
9 Recruiting Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Conditions: HPV16+;   Cervical Intraepithelial Neoplasia (CIN 2/3)
Interventions: Biological: DNA vaccination;   Device: Gene gun vaccine;   Biological: intramuscular vaccination;   Biological: intra-lesional vaccine administration;   Procedure: therapeutic resection of the lesion
10 Completed Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant
Condition: Influenza
Interventions: Biological: Fluzone vaccine with JVRS-100 adjuvant;   Biological: Fluzone vaccine
11 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Conditions: Poliomyelitis;   Tropical Enteropathy
Intervention: Biological: IPV vaccination
12 Recruiting A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Belimumab plus Early Vaccination;   Biological: Belimumab plus Late Vaccination
13 Terminated Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
Condition: Malignant Melanoma Stage IV
Interventions: Biological: DC Vaccine & Cyclophosphamide;   Biological: DC Vaccine & Placebo
14 Completed Efficacy Study of T Cell Vaccination in HIV Infection
Condition: HIV Infections
Intervention: Biological: T cell vaccination
15 Active, not recruiting Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: Placebo for ALVAC-HIV;   Biological: Placebo for AIDSVAX B/E;   Biological: Hepatitis B vaccine;   Biological: Tetanus toxoid vaccine;   Biological: Placebo for hepatitis B vaccine;   Biological: Placebo for tetanus vaccine
16 Recruiting Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer
Conditions: Lung Cancer;   Adenocarcinoma
Interventions: Biological: GM.CD40L.CCL21 Vaccinations;   Biological: GM.CD40L cells Vaccinations
17 Withdrawn Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1
Condition: Influenza
Interventions: Biological: Vaccine Sanofi A(H1N1) 15 ug & trivalent;   Biological: Vaccine Sanofi (H1N1) 15 ug.nonadyuvante;   Biological: Vaccine Sanofi A(H1N1) 7.5 ug
18 Completed
Has Results
Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART
Condition: HIV Infections
Interventions: Biological: LC002 standard vaccination;   Biological: LC002 high-dose vaccination;   Biological: LC002 placebo vaccination
19 Completed Polio NID and Routine EPI Integration Trial Pakistan
Condition: Polio
Interventions: Behavioral: Vaccine promotion messages;   Other: Vaccination Verification.;   Other: Distribution of Plastic Pouches to retain vaccination card
20 Recruiting Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
Conditions: Hepatitis B;   Cirrhosis;   Awaiting Organ Transplant
Intervention: Biological: HBV vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years